These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2265247)

  • 1. Sulfation of von Willebrand factor.
    Carew JA; Browning PJ; Lynch DC
    Blood; 1990 Dec; 76(12):2530-9. PubMed ID: 2265247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies.
    Vischer UM; Wagner DD
    Blood; 1994 Jun; 83(12):3536-44. PubMed ID: 8204880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor.
    Lynch DC; Zimmerman TS; Ling EH; Browning PJ
    J Clin Invest; 1986 Jun; 77(6):2048-51. PubMed ID: 3486890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimer size dependence of von Willebrand factor binding to crosslinked or noncrosslinked fibrin.
    Ribes JA; Francis CW
    Blood; 1990 Apr; 75(7):1460-5. PubMed ID: 2107883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subendothelial matrix of cultured endothelial cells contains fully processed high molecular weight von Willebrand factor.
    Tannenbaum SH; Rick ME; Shafer B; Gralnick HR
    J Lab Clin Med; 1989 Mar; 113(3):372-8. PubMed ID: 2784474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains.
    Fretto LJ; Fowler WE; McCaslin DR; Erickson HP; McKee PA
    J Biol Chem; 1986 Nov; 261(33):15679-89. PubMed ID: 3536910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage.
    Berkowitz SD; Federici AB
    Blood; 1988 Nov; 72(5):1790-6. PubMed ID: 2460162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of normal and type 2A von Willebrand factor in the rat.
    Stoddart JH; Andersen J; Lynch DC
    Blood; 1996 Sep; 88(5):1692-9. PubMed ID: 8781425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
    Hamilton KK; Fretto LJ; Grierson DS; McKee PA
    J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.
    Furlan M; Robles R; Lämmle B
    Blood; 1996 May; 87(10):4223-34. PubMed ID: 8639781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte proteases do not process endothelial cell-derived unusually large von Willebrand factor multimers to plasma vWF in vivo.
    Phillips MD; Vu C; Nolasco L; Moake JL
    Am J Hematol; 1991 Jun; 37(2):80-3. PubMed ID: 2069167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.
    de Groot PG; Federici AB; de Boer HC; d'Alessio P; Mannucci PM; Sixma JJ
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3793-7. PubMed ID: 2657729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.
    Bockenstedt P; Greenberg JM; Handin RI
    J Clin Invest; 1986 Mar; 77(3):743-9. PubMed ID: 2936763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormality of the N-terminal portion of von Willebrand factor in type IIA and IIC von Willebrand disease.
    Takahashi Y; Kalafatis M; Girma JP; Meyer D
    Thromb Haemost; 1988 Dec; 60(3):498-505. PubMed ID: 3266380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimeric composition of endothelial cell-derived von Willebrand factor.
    Tsai HM; Nagel RL; Hatcher VB; Sussman II
    Blood; 1989 Jun; 73(8):2074-6. PubMed ID: 2786433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls.
    Mayadas TN; Wagner DD
    J Biol Chem; 1989 Aug; 264(23):13497-503. PubMed ID: 2788160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers.
    Bendetowicz AV; Morris JA; Wise RJ; Gilbert GE; Kaufman RJ
    Blood; 1998 Jul; 92(2):529-38. PubMed ID: 9657753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rickettsia rickettsii infection of cultured endothelial cells induces release of large von Willebrand factor multimers from Weibel-Palade bodies.
    Sporn LA; Shi RJ; Lawrence SO; Silverman DJ; Marder VJ
    Blood; 1991 Nov; 78(10):2595-602. PubMed ID: 1824255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of human von Willebrand factor by platelet calcium-activated protease.
    Kunicki TJ; Montgomery RR; Schullek J
    Blood; 1985 Feb; 65(2):352-6. PubMed ID: 2981585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.